Showing results (131-140 of 460) with videos related to

Sort By:
Pageof 46
Endocrine Connections|March 13, 2020
Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunctionAnna Olsson-Brown, Rosemary Lord, Joseph Sacco, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|May 14, 2011
Brief interventions in dependent drinkers: a comparative prospective analysis in two hospitalsKathryn Cobain, Lynn Owens, Ruwanthi Kolamunnage-Dona, et al.
British Journal of Clinical Pharmacology|March 9, 2005
Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liverAndrew Owen, Chris Goldring, Paul Morgan, et al.
Toxicology and Applied Pharmacology|July 6, 2005
Investigation of toxic metabolites during drug developmentKevin Park, Dominic P Williams, Dean J Naisbitt, et al.
Pharmacoepidemiology and Drug Safety|August 23, 2023
Adverse drug reactions and hospital admissions: Large case-control study of patients aged 65-100 years using linked English primary care and hospital dataTjeerd Pieter van Staa, Munir Pirmohamed, Anita Sharma, et al.
Genes|November 4, 2020
A Review of the Important Role of CYP2D6 in PharmacogenomicsChristopher Taylor, Ian Crosby, Vincent Yip, et al.
Clinical and Translational Science|May 11, 2026
Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology LiteratureCinzia Dello Russo, Luigi Venetucci, Abisope Akintola, et al.
British Journal of Clinical Pharmacology|March 8, 2014
Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatmentTjeerd P van Staa, Daniel F Carr, Helen O'Meara, et al.
British Journal of Clinical Pharmacology|October 20, 2020
Warfarin dosing algorithms: A systematic reviewInnocent G Asiimwe, Eunice J Zhang, Rostam Osanlou, et al.
Pageof 46